Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products.

Interleukin has two primary focus areas. The first is personalized health, which is primarily focused on providing personal genetic tests from Inherent Health to customers. These products are distributed via sales partners and our own sales channels, with the goal of providing guidance for the individual interested in improving his or her health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels.

Learn more at ilgenetics.com

Board of Directors

James M. Weaver
Vice President, Managing Director – Alticor Corporate Enterprises

Lewis H. Bender
Chief Executive Officer – Interleukin Genetics

Mary E. Chowning

Thomas R. Curran, Jr.
Director – Alticor Enterprises

Catherine Ehrenberger
VP R&D/QA Divison, - Amway

William C. Mills III